文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,550+ SCI 论文 与阿拉丁产品引用相关
2,304,480.59 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第5581至5592个,产品总数347,550个

切换升序
JOURNAL OF MEDICINAL CHEMISTRY · 2026 · IF 7.3

Discovery of Novel Thiazolo[4,5-d]pyrimidin-7(6H)-Ones as Extrasynaptic δ-GABAA Receptor-Preferring PAMs with Rapid Antidepressant-like Efficacy

Han Wang,Weiming Liao,Yunzhe Li,Aiping Guo,Zhenyu Liu,Xinyu Guo,Kexin Wang,Yulin Zheng,Zihan Wang,Wei Wang,Xiaowei Wang,Liangren Zhang,Qi Sun,Zhuo Huang

Activation of extrasynaptic δ-GABAARs represents a promising strategy for rapid-acting antidepressant therapy in major depressive disorder (MDD). Here, we report the discovery and pharmacological characterization of a novel series of thiazolo[4,5-d]pyrimidin-7(6H)-one derivatives as potent positive allosteric modulators selective for δ-GABAARs. Systematic SAR exploration identified compound 12i as a lead candidate, which demonstrated high potency on the extrasynaptic receptor subtype (α4β3δ: 950% current enhancement at 10 μM, EC50 = 0.8 μM) while maintaining favorable modulation of synaptic subtypes. In vivo, 12i exerted rapid-acting antidepressant effects in both the mouse tail suspension test and the chronic restraint stress-induced depression model, with no addictive behaviors observed. These effects were completely abolished in δ-subunit knockout mice, confirming target engagement. Furthermore, 12i significantly enhanced NREM sleep in a p-chlorophenylalanine-induced insomnia model, highlighting potential dual efficacy in MDD with comorbid sleep disturbance. Collectively, these findings position 12i as a promising clinical candidate for next-generation rapid-acting antidepressant therapy.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH · 2026 · IF 3.9

COSMO-RS Guided Sustainable Separation of Squalene from Soybean Oil Deodorizer Distillate Waste Using Biocompatible Ionic Liquids

Fanding Rong,Fuxing Shen,Zexiang Ding,Ping Lu,Liu Yang,Yifeng Cao,Qiwei Yang,Zhiguo Zhang,Qilong Ren,Zongbi Bao

Efficient recovery of value-added compounds from biomass waste represents a sustainable approach to chemical engineering. This study presents an innovative and environmentally benign approach for squalene purification from unsaponifiable soybean oil deodorizer distillate (SODD) waste using biocompatible ionic liquids (ILs) in a liquid–liquid extraction process. Employing a conductor-like screening model for real solvents (COSMO-RS)-guided methodology coupled with a push-and-pull strategy, we systematically screened and identified the optimal biphasic extraction systems. The optimized system utilizing 1 mol % [Ch][CnH2n+1COO] in N-methyl-2-pyrrolidinone achieved exceptional impurity-to-squalene selectivity over 15 while maintaining suitable distribution coefficients. Comprehensive mechanistic investigations through quantum-chemical calculations and nuclear magnetic resonance spectroscopy revealed a hydrogen-bond-dominated separation mechanism. Multistage extraction optimization demonstrated the capability to simultaneously achieve high purity and superior recovery rates of squalene. This research establishes a sustainable, high-performance pathway for valorizing refinery waste streams, offering significant implications for green chemistry and circular economy principles in the biorefinery industry.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
LANGMUIR · 2026 · IF 4.4

Polyaniline and Polyacrylic Acid Reinforced Mechanical Strength and Conductivity at the Interface of Silicon Anodes

Fulin Wang,Yulin Wu,Wenhui Fu,Yin Zhao,Yuxuan Tian,Jingyao Wang,Xuzhong Gong

The poor cycling stability of silicon-based anodes in lithium-ion batteries (LIB) presents a thorny issue. We devise a strategy to regulate covalent and noncovalent interactions at the silicon-based anode interface, balancing electrode conductivity and stability. The polyaniline-poly(acrylic acid)-sodium carboxymethyl cellulose (PPC) binder is synthesized via in situ polymerization/thermal cross-linking, which utilizes the noncovalent interactions of polyaniline and the covalent interactions of O═C–O–M (Si/Cu/C) bonds to resolve the issue of asynchrony between conductivity and stability. The continuous conductive network structure formed by polyaniline, doped and gelled with 5-sulfosalicylic acid, addresses the problem of electrical connection failure in silicon-based anodes. The O═C–O–C bonds (PAA–CMC) enhance the covalent cohesion between binder molecules, preventing electrolyte swelling. The O═C–O–Si bonds enhance the covalent binding between the binder and the silicon particle interface. The covalent O═C–O–Cu bonds boost the binder–copper interface interaction, improving the interfacial stability of the entire electrode. After 1000 ultralong cycles at 1 A g–1, the nanosilicon anode with the PPC binder delivers a reversible capacity of 1130 mAh g–1. This work demonstrates a promising strategy for enhancing interfacial stability and conductivity in silicon-based anodes, offering a practical solution to improve long-term cycling performance.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
Bioactive Materials · 2026 · IF 23.6

Mechanically preconditioned stem cells therapy using bioinspired liver-mimetic microspheres for functional liver repair

Tiantian Xue,Jiabin Zhang,Bin Wang,Fenfang Li,Guipan Chen,Yanteng Xu,Yuechen Luo,Jiali Sun,Yeh-Hsing Lao,Jin Wang,Haixia Wang,Enguo Ju,Xi Xie,Haochen Yao,Mingqiang Li,Yu Tao

Hepatocyte-like cells (HLCs) represent a promising therapeutic approach for acute liver failure (ALF), offering an alternative to primary hepatocytes, which are in short supply. Given the viscoelastic tissue properties of the liver and the growing recognition of the mechanical cues in physiology and disease, we investigated how ALF-induced changes in the liver's mechanical microenvironment might affect HLC-based cell therapy. Here, driven by specific disease-derived mechanical cues, we designed bioinspired hydrogel microspheres with tunable liver viscoelasticity to mimic the mechanical niche of healthy versus ALF liver tissue. We show that a fast-relaxation hydrogel niche mimicking the healthy liver guides the efficient differentiation of human adipose-derived mesenchymal stem cells (hADSCs) into functional HLCs by suppressing the formation of abnormal stress fibers and pathological YAP nuclear translocation through the ROCK axis. In both the carbon tetrachloride-induced and partial hepatectomy-induced ALF mouse models, these mechanically preconditioned HLCs exhibit significant therapeutic efficacy, promoting robust liver regeneration and acting as active mechanical regulators to suppress aberrant host mechanotransduction and remodel the diseased microenvironment. This disease mechanobiology-oriented strategy provides insights into the design of viscoelastic biomaterials for regenerative medicine and demonstrates a promising approach for enhancing cell therapy outcomes in liver failure.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
RESPIRATORY RESEARCH · 2026 · IF 5.7

MyD88 mediates allergic airway inflammation by regulating ILC2s function through inducing the formation of P38/GATA3 complex

Hui Zhang,Wei Dai,Xuanyu Chen,Xinru Xi,Yeqing Chen,Jingjing Song,Xiangting Ge,Qiangwei Xiang,Bing Zhang,Chengguang Zhao,Weixi Zhang,Yali Zhang

Background: Allergic asthma stands as the predominant asthma phenotype propelled by aberrant type 2 immune response. Type-2 innate lymphoid cells (ILC2s) are significant for generating IL-5 and IL-13 cytokines, highlighting their vital role in triggering and escalating the progression of asthma. Myeloid differentiation primary response protein 88 (MyD88) controls innate and adaptive immune responses by orchestrating inflammatory signals. Objective: This work focused on investigating the influence of MyD88 in governing ILC2s-driven allergic airway disease alongside its underlying molecular mechanisms. Methods: We evaluated the effects of MyD88 in IL-33-induced or allergen-induced airway hyperreactivity (AHR) and airway inflammation. The role and mechanism of MyD88 in regulating ILC2s function were examined in vivo and in vitro by using transcriptome sequencing analysis, flow cytometry, clinical samples, ILC2-specific MyD88 knockout mice, and anti-Thy1.2 antibody against ILC2s in mice. Results: The results showed heightened MyD88 expression in ILC2s sourced from allergic asthmatic patients and asthmatic mice. MyD88 knockout in ILC2s was able to mitigate IL-33-induced airway inflammation, while the MyD88 inhibitor LM8 proves efficacious in attenuating allergen-induced airway inflammation and AHR. After elimination of ILC2s via anti-Thy1.2 antibody, the pharmacological activity of LM8 diminished. Mechanistic studies revealed that MyD88 mediates the activation and proliferation of ILC2s through facilitation of P38-GATA3 complex formation. Conclusions: The research highlights MyD88 as a critical regulator of ILC2s activation, suggesting its potential utility as a therapeutic target for interventions in allergic asthma.

CAS / MDL: 8001-25-0
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Applied Materials & Interfaces · 2026 · IF 7.8

A pH-Responsive Antimicrobial Peptide Coating with Efficient Antibacterial Activity and Preserved Oral Microbiota Homeostasis during Clear Aligner Treatment

Mengyu Li,Yan Sun,Jiamei Wang,Yuxiang Zhang,Tongzhan Dou,Chen Chen,Bo Yuan,Pengfei Cui,Yang Liu

Bacterial adhesion and biofilm formation pose significant clinical challenges in clear aligner therapy, adversely affecting both oral health and aesthetics. In this study, a machine learning-driven strategy was used to develop a novel antimicrobial peptide (AMP), IW (sequence: IDFYRKTHWWNKLLAKWWAMR), which was subsequently covalently immobilized onto the surface of clear aligners to construct a pH-responsive antibacterial coating. In response to cariogenic acidic microenvironments, the coating is specifically activated to effectively inhibit the proliferation of cariogenic bacteria and subsequent biofilm formation. Moreover, IW reduces the abundance of potential pathogens while enriching health-associated bacterial genera, exerting a beneficial modulatory effect on the oral microbiome. This dual-functional strategy, integrating antibacterial activity with microbiota homeostasis preservation, offers a promising approach to combat cariogenic bacterial infection and oral dysbiosis, presenting substantial potential for clinical translation in orthodontic applications.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Applied Materials & Interfaces · 2026 · IF 7.8

Chirality-Dependent Treatment of Ulcerative Colitis by Chiral Nanosheets

Chongyang Tang,Lei Wu,Xinxin Zhang,Lijuan Xie,Ziwen Xiao,Deyan Gong,Zhengbao Zha,Zhaohua Miao

Chirality, an inherent property that is ubiquitous in nature, plays a vital role in biological processes. However, the impact of chiral materials on inflammatory diseases remains incompletely elucidated. Herein, chiral black phosphorus nanosheets (BP NSs), prepared through a chirality-transfer-assisted liquid exfoliation approach, exhibited chirality-dependent treatment efficiency of ulcerative colitis (UC). Benefiting from chirality-dependent cellular uptake via both clathrin- and caveolin-mediated endocytic pathways, L-BP NSs exhibited stronger cellular ROS scavenging than D-BP NSs. Upon oral administration, L-BP NSs exhibited superior intestine accumulation capability due to chiral nanosheet-mediated cascade targeting, that is, negatively charged L-BP NSs initially absorbed in the positively charged inflamed intestinal epithelium via electrostatic adsorption, followed by enhanced cellular uptake via chirality-dependent endocytosis. Meanwhile, L-BP NSs selectively enriched beneficial bacteria (e.g., Lactobacillus) and suppressed harmful ones (e.g., Proteobacteria), leading to a gut microbiota balance. In the delayed therapeutic UC model, the L-BP NSs group achieved an average colon length of 8.24 cm, longer than those of the D-BP NS (7.16 cm) and DL-BP NS (7.60 cm) groups. This study opens an avenue for the application of chiral BP NSs in UC and provides a chirality-dependent target treatment strategy for inflammatory diseases.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Nano · 2026 · IF 17.3

Dissecting Discoidin Domain Receptor 2 Dynamics in Fibrosis with a Programmable Collagen-Mimetic Probe

Yinghua Liu,Xufei Wang,Xiaotong Ma,Lu Huang,Penghui Yang,Tao Li,Wenjun Wu,Daoning Zhou,Jin Su,Yang Li

Collagen receptors orchestrate vital extracellular matrix signaling, yet the inability to distinguish functional receptor activation from mere expression in real-time has obscured our understanding of fibrotic progression. Here, we develop a fluorescent triple-helical collagen-mimetic peptide (CMP) probe, [GVMGFO]3, designed to selectively target the ligand-engaging conformation of Discoidin Domain Receptor 2 (DDR2)─the sole receptor tyrosine kinase family that signals collagen. In pulmonary fibrosis, this probe identifies active fibrotic niches in vivo and directly tethers to disease-driving activated fibroblasts to enable precise ex vivo mapping, all without perturbing baseline signaling. Utilizing this tool, we decipher the long-standing mystery of DDR2’s characteristically slow, hours-long activation kinetics. We reveal that while monomeric collagen engagement fails to override constitutive DDR2 internalization, supramolecular fibrillar collagen provides a multivalent physical anchor that arrests DDR2 trafficking at the cell–matrix interface to sustain receptor clustering and phosphorylation. To recapitulate this biophysical requirement, we engineered Zn2+-coordinated supramolecular assemblies of a histidine-modified CMP, [H-GVMGFO-H]3, triggering rapid DDR2 activation within minutes. Our work transforms CMPs from structural models of collagen into programmable chemical tools for dissecting the spatiotemporal dynamics of collagen–receptor interplay, offering a platform for imaging and modulating fibrotic disease.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
MOLECULAR PHARMACEUTICS · 2026 · IF 4.9

Targeting NETosis in the Lung: Respiratory Delivery of Neutrophil-Specific NEBP-Liposomes for Enhanced Therapy of Acute Lung Injury

Xin Liu,Yun Liu,Wuqi Guo,Xinghua Li,Yiran Han,Qiang Huo,Yang Liu,Yimin Niu

The activation, adhesion, and migration of neutrophils are one of the main reasons for the progression of acute lung injury (ALI) and a new therapeutic target for ALI. Although respiratory administration for ALI has the characteristics of targeted drug delivery, some issues, such as the drug’s short residence time in the lungs, rapid clearance rate, and lack of specificity for neutrophils, make it difficult to maintain an effective drug concentration. Here, we designed and evaluated a neutrophil-targeting peptide NEBP-modified andrographolide liposome (N-Lip@A) that can be administered via the respiratory tract to inhibit the formation of neutrophil extracellular traps, aiming to provide a rapid, efficient, and precise intervention strategy for ALI. N-Lip@A liposomes were synthesized by the traditional thin-film hydration method. Cell immunofluorescence and scanning electron microscopy observations indicated that N-Lip@A could reduce the formation of neutrophil extracellular traps (NETs). Quantitative analysis using the PicoGreen assay showed that the release of double-stranded DNA (dsDNA) in the N-Lip@A group was reduced to 57.9% compared with the untreated PMA group, and its effect was superior to that of the nontargeted liposome formulation (Lip@A). SYTOX staining, CCK8 assay, and Calcein-AM/PI staining results demonstrated that N-Lip@A could reduce the death of PMA-stimulated neutrophils. Besides, compared with the untreated group, the supernatant from neutrophils pretreated with N-Lip@A increased the survival rate of alveolar epithelial MLE-12 cells. In a lipopolysaccharide-induced murine model of ALI, compared with the nontargeted Lip@A group or the untreated group, the pathological lung injury score decreased to 52.6% and 31.6%, respectively. Significant disease remission, including reduced pulmonary edema, restored integrity of the blood–air barrier, and improved alveolar architecture were also demonstrated through EB staining analysis, lung wet-to-dry weight ratio determination, and HE staining analysis. Collectively, N-Lip@A enables precise delivery of AGL to activated neutrophils via NEBP-mediated targeting, effectively inhibiting NETs formation and mitigating ALI-associated pathological damage. This strategy provides an expandable targeted drug delivery platform for the treatment of various acute or chronic pulmonary inflammatory diseases driven mainly by neutrophils.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
DRUG DELIVERY · 2026 · IF 8

Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4

Wanting Jiang,Hao Zheng,Shengmei Wang,Rubing Xu,Xi Chen,Jing Yang,Xinhua Xia

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, yet conventional chemotherapy is limited by poor tumor specificity and severe toxicity. Cantharidin (CTD), a natural antitumor agent, is hindered by nephrotoxicity and hepatotoxicity. This study aimed to construct a dual-ligand-modified CTD-loaded solid lipid nanoparticle (GA-FA-CSLNs) using 18-glycyrrhetinic acid (GA) for hepatocyte targeting and folate-PEG3500-DSPE (FA) for long circulation, and to evaluate its antitumor efficacy, mechanism, and safety. GA-FA-CSLNs were prepared by emulsification-ultrasonication and optimized via Box-Behnken design. The nanoparticles were characterized. In vitro antitumor activity was assessed in Huh-7 cells using CCK-8, flow cytometry, and Western blotting. In vivo efficacy and safety were evaluated in Huh-7 tumor-bearing nude mice, and pharmacokinetics in SD rats. GA-FA-CSLNs exhibited favorable physicochemical properties. In vitro studies showed enhanced cellular uptake, the lowest IC50, and 43.2% apoptosis in Huh-7 cells. Mechanistically, GA-FA-CSLNs downregulated Eph receptor B4(EphB4) and Bcl-2, while upregulating caspase-3 and Bax. In vivo, the tumor inhibition rate reached 58.67%, superior to free CTD and sorafenib, with 100% 14-day survival and no significant abnormalities in serum biochemistry or histopathology. Pharmacokinetic analysis showed prolonged elimination half-life (2.54 h) and a 3.2-fold increase in area under the blood concentration-time curve versus unmodified CSLNs. GA-FA-CSLNs represent a promising actively targeted nanoplatform that enhances CTD antitumor efficacy against HCC via EphB4 pathway inhibition while reducing systemic toxicity, offering a potential strategy for targeted HCC therapy.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
Virulence · 2026 · IF 6.8

Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against Candida albicans

Jing Yao,Zhiyu Yang,Xudong Hang,Tianyu Chen,Binglei Li,Ting Shi,Keao Quan,Jingchen Xu,Liping Zeng,Ganzhu Feng,Hongkai Bi

Fungal infections represent a significant and growing threat to public health, exacerbated by an expanding population of immunocompromised individuals and the increasing prevalence of resistance to conventional antifungal agents. Drug repurposing offers a strategic and efficient pathway for antifungal discovery, leveraging existing pharmacotherapies to reduce development costs and mitigate safety risks. This study evaluated the antifungal potential of pinaverium bromide, an FDA-approved antispasmodic drug for functional gastrointestinal disorders, against the prevalent pathogen Candida albicans. Our in vitro analyses revealed that pinaverium bromide demonstrated standalone antifungal activity and acted synergistically with amphotericin B or azole drugs. Moreover, it effectively attenuated key virulence factors of C. albicans, including hyphal formation and biofilm development. The therapeutic efficacy of both monotherapy and combination therapy with amphotericin B or voriconazole was validated in two murine models of systemic candidiasis. Mechanistically, pinaverium bromide disrupted mitochondrial function, induced apoptotic cell death, and impaired iron homeostasis in C. albicans. When combined with amphotericin B, it potentiated the drug’s effect by amplifying reactive oxygen species accumulation and enhancing membrane permeabilization. These findings support the potential of pinaverium bromide as a novel antifungal agent, either when used alone or in combination with established antifungal therapies.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
Journal of Animal Science and Biotechnology · 2026 ·Vol. 17 ·期 1 ·110 · IF 7.9

Near-complete inhibition of rumen methanogenesis via microbial and enzymatic modulation using a low dose of Asparagopsis taxiformis combined with 3-nitrooxypropanol

Li Shuai,Sun Yi,Tong Xiong,Zhang Zhifei,Ma Xinyan,Li Dagang,Min Li

Background Enteric methane (CH 4 ) from ruminants represents a major contributor to agricultural greenhouse gas emissions. The red seaweed Asparagopsis taxiformis ( A. taxiformis ) is a highly effective CH 4 emission inhibitor, but its large-scale application is restricted by limited biomass availability. This study evaluated whether reducing the inclusion level of A. taxiformis (0.32% dry matter, DM) combined with 3-nitrooxypropanol (3-NOP; 0.05% DM) could maintain a high inhibitory efficacy, and elucidated the underlying microbial mechanisms through in vitro fermentation and metagenomics analysis. Results The combined treatment decreased CH 4 production by 98.21% ( P  < 0.01) without impairing DM degradation, and markedly shifted rumen fermentation towards propionate, lowering the acetate-to-propionate ratio (1.59 vs. 2.65; P  < 0.01). Metagenomic profiling revealed substantial reductions in the abundance of Methanobrevibacter and Ruminococcus , along with increased levels of propionate-associated bacteria such as Prevotella , Treponema , Eubacterium , and Selenomonas ( P  < 0.01). Functionally, the combined treatment downregulated key enzymes in hydrogenotrophic and methylotrophic methanogenesis, including methyl-coenzyme M reductase (EC:2.8.4.1) and tetrahydromethanopterin S-methyltransferase (EC:2.1.1.86), thereby blocking terminal methanogenic steps. Conclusions Collectively, these results demonstrate that co-supplementation with A. taxiformis and 3-NOP achieves near-complete methanogenesis inhibition at drastically reduced seaweed dosage through coordinated changes in fermentation patterns, microbial community structure, and methanogenic enzymatic pathways. This approach provides a practical strategy to overcome biomass limitations of A. taxiformis and warrants validation in long-term in vivo trials.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。